Atreca rakes in $35 mln Series B
Redwood City, California-based Atreca Inc, a biotechnology company focused on developing novel therapeutics, has closed $35 million in Series B financing. The investors included Wellington Management Company and Cormorant Asset Management.
17 August 2017•1 min read
